CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR ‐140‐5p/ LMNB1 axis
Cancer Medicine · 2023
DOI: 10.1002/cam4.5869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Wen Fu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Science and Technology Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Growing evidences suggest that circular RNAs (circRNAs) are important factors in cancer progression. Nevertheless, the role of circRNAs in the progression of pancreatic ductal adenocarcinoma (PDAC) remains unclear.
Methods
CircPTPRA was identified based on our previous circRNA array data analysis. Wound healing, transwell, and EdU assays were performed to investigate the effect of circPTPRA on the migration, invasion, and proliferation of PDAC cells in vitro. RNA pull‐down, fluorescence in situ hybridization (FISH), RNA immunoprecipitation (RIP), and dual‐luciferase reporter assays were conducted to verify the binding of circPTPRA with miR‐140‐5p. Subcutaneous xenograft model was constructed for in vivo experiment.
Results
CircPTPRA was significantly upregulated in PDAC tissues and cells compared to normal controls. Moreover, circPTPRA overexpression was positively correlated with lymph node invasion and worse prognosis in PDAC patients. In addition, overexpression of circPTPRA promoted PDAC migration, invasion, proliferation, and epithelial‐mesenchymal transition (EMT) in vitro and in vivo. Mechanistically, circPTPRA upregulates LaminB1 (LMNB1) expression by sponging miR‐140‐5p and ultimately promotes the progression of PDAC.
Conclusions
This study revealed that circPTPRA plays an important role in the progression of PDAC by sponging miR‐140‐5p. It can be explored as a potential prognostic marker and therapeutic target for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Medical University, Chongqing, 400016, China.
- Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing, 400174, China.
- Chongqing School, University of Chinese Academy of Sciences, Chongqing, 400013, China.
- Department of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, 401147, China.
- Chinese Academy of Sciences, Beijing, 101400, China.
- NHC Key Laboratory of Birth Defects and Reproductive Health, Chongqing Population and Family Planning Science and Technology Research Institute, Chongqing, 400020, China.
ORCID-Profile: Wen Fu
Förderung
- Chongqing Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Fu, W., Wang, X., Xiang, J., Chen, S., Xia, R., Xie, F., Chi, B., Qin, F., Li, Z., Mou, L., Xie, C., & Wang, H. (2023). CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR ‐140‐5p/ LMNB1 axis. Cancer Medicine. https://doi.org/10.1002/cam4.5869
Vancouver
Fu W, Wang X, Xiang J, Chen S, Xia R, Xie F, et al. CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR ‐140‐5p/ LMNB1 axis. Cancer Medicine. 2023. doi:10.1002/cam4.5869
BibTeX
@article{Fu2023,
author = {Fu, Wen and Wang, Xianxing and Xiang, Jifeng and Chen, Shengkai and Xia, Renpei and Xie, Fuming and Chi, Bojing and Qin, Fanbo and Li, Zhuo and Mou, Li and Xie, Chuanming and Wang, Huaizhi},
title = {CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR ‐140‐5p/ LMNB1 axis},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5869}
}
EUVIMED